COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,625 Articles (22,913 medRxiv, 8,712 bioRxiv)

Most recent first Previous |  Page 1216: Articles 12151-12160  | Next

Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
Korosec, C. S., farhangsardroodi, s. S., Dick, D. W., Gholami, S., Ghaemi, M. S., Moyles, I. R., Craig, M., Ooi, H. K., Heffernan, J. M.
10.1101/2021.10.13.21264957 — Posted: 2021-10-18
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort
Ward, A., Sarraju, A., Lee, D., Bhasin, K., Gad, S., Beetel, R., Chang, S., Bonafede, M., Rodriguez, F., Dash, R.
10.1101/2021.10.15.21264137 — Posted: 2021-10-18
Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers
Laing, E. D., Weiss, C. D., Samuels, E. C., Coggins, S. A., Wang, W., Wang, R., Vassell, R., Sterling, S. L., Tso, M. A., Conner, T., Goguet, E., Jackson-Thompson, B. M., Illinik, L., Davies, J., Ortega, O., Parmelee, E., Hollis-Perry, M., Maiolatesi, S. E., Wang, G., Ramsey, K. F., Reyes, A. E., Alcorta, Y., Wong, M. A., Lindrose, A. R., Duplessis, C. A., Tribble, D. R., Malloy, A. M., Burgess, T. H., Pollett, S. D., Olsen, C. H., Broder, C. C., Mitre, E.
10.1101/2021.10.16.21265087 — Posted: 2021-10-18
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020
Shapiro, A. E., Bender Ignacio, R. A., Whitney, B. M., Delaney, J. C., Nance, R. M., Bamford, L., Wooten, D., Keruly, J. C., Burkholder, G., Napravnik, S., Mayer, K. H., Webel, A. R., Kim, H. N., Van Rompaey, S., Christopoulos, K., Jacobson, J., Karris, M., Smith, D., Johnson, M. O., Willig, A., Eron, J. J., Hunt, P., Moore, R. D., Saag, M. S., Mathews, W. C., Crane, H. M., Cachay, E. R., Kitahata, M. M.
10.1101/2021.10.15.21265063 — Posted: 2021-10-18
SARS-CoV-2 Pandemic Preventive Methods Efficacy - A Simulation Case Study
Saad, M., Boctor, E. M.
10.1101/2021.10.17.21265111 — Posted: 2021-10-18
Evaluation of viral loads in patients with SARS-CoV-2 Delta variant infection: Higher loads do not translate into different testing scenarios
Marti, J. L. G., Mays, A., McCullough, M., Wells, A., Phan, T.
10.1101/2021.10.14.21265031 — Posted: 2021-10-18
Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
Caspersen, I. H., Magnus, P., Trogstad, L.
10.1101/2021.10.15.21265038 — Posted: 2021-10-18 Discussion: Onsite
SEIRDQ: A COVID-19 case projection modeling framework using ANN to model quarantine
Chandra, H., Meng, X., Margaryan, A.
10.1101/2021.10.15.21265056 — Posted: 2021-10-18
Simulation and predictions of a new COVID-19 pandemic wave in Ukraine with the use of generalized SIR model
Nesteruk, I.
10.1101/2021.10.13.21264949 — Posted: 2021-10-18 Discussion: Onsite
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
Konig, M., Torgauten, H. M., Overas, M. H., Chopra, A., Lorentzen, A. R., Tran, T. T., Mjaaland, S., Aaberge, I. S., Myhr, K.-M., Wergeland, S., Berge, T., Harbo, H. F., Torkildsen, O. F. G., Holmoy, T., Celius, E. G., Munthe, L. A., Vaage, J. T., Lund-Johansen, F., Nygaard, G. O.
10.1101/2021.10.15.21264977 — Posted: 2021-10-18 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).